SDMHF — Sartorius Stedim Biotech S.A./ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 1794363 ·
Last close
$244.00
Market Cap
$23.74B
52W High
$263.24
52W Low
$177.58
ADV30
2,593
Next earnings
2026-10-22
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 765,700,000 | 358,800,000 | 154,000,000 | 93,000,000 | 7,917,500,000 | 203,900,000 | 3,670,600,000 |
| Mar 2026 | 761,500,000 | 345,400,000 | 149,300,000 | 88,100,000 | 8,189,800,000 | 521,200,000 | 4,046,800,000 |
| Dec 2025 | 772,200,000 | 316,900,000 | 134,400,000 | 47,300,000 | 7,984,000,000 | 426,100,000 | 3,857,900,000 |
| Jun 2025 | 745,000,000 | 344,700,000 | 129,000,000 | 68,500,000 | 8,312,400,000 | 699,300,000 | 4,273,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$712,600,000
Investing CF
$-338,100,000
Financing CF
$-887,900,000
CapEx
$-335,400,000
Dividends Paid
$0
Buybacks
$-1,400,000
EPS Diluted TTM
$3.45
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$2,793,400,000
Inventory
$714,300,000
Receivables
—
ST Investments
$28,900,000
EBIT TTM
$527,000,000
Pretax Income TTM
$416,200,000
Interest Exp TTM
$110,800,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,005,100,032
EBITDA
$816,400,000
Free Cash Flow
$202,424,992
Enterprise Value
$23,509,274,624
Total Cash
$204,200,000
Total Debt
$2,402,599,936
Shares Out
97,292,500
Trailing EPS
$3.50
Book Value
$50.79
ROE
7.1%
ROA
4.4%
Div Yield
0.36%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,967,500,000 | 539,400,000 | 265,600,000 | 7,984,000,000 | 3,857,900,000 | 4,090,500,000 | 692,200,000 |
| Dec 2024 | 2,780,000,000 | 397,600,000 | 175,100,000 | 8,256,400,000 | 4,232,600,000 | 3,986,600,000 | 815,100,000 |
| Dec 2023 | 2,775,500,000 | 471,200,000 | 310,300,000 | 7,730,100,000 | 5,056,300,000 | 2,638,500,000 | 746,400,000 |
| Dec 2022 | 3,492,700,000 | 1,055,000,000 | 876,100,000 | 5,065,400,000 | 2,551,200,000 | 2,449,300,000 | 612,300,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TPR | TAPESTRY, INC. | $23.55B | $118.12 | — |
| TPL | Texas Pacific Land Corp | $23.46B | $340.19 | — |
| VLTO | Veralto Corp | $23.08B | $94.68 | — |
| CAJFF | CANON INC | $25.12B | $29.76 | — |
| IVBXF | Innovent Biologics Inc/ADR | $22.32B | $12.80 | — |
News headlines (Yahoo Finance, 1h cache)
Sartorius Stedim Biotech SA (SDMHF) Q2 2026 Earnings Call Highlights: Strong Growth Amid Tariff ...
2026-07-23 19:00 · Yahoo
Sartorius Stedim Biotech SA (SDMHF) Q4 2025 Earnings Call Highlights: Strong Profit Growth and ...
2026-02-03 19:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.